KMK HEALTH, LLC – Trademark Portfolio
Entity Type: 16
KMK HEALTH, LLC has 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include ALLERGY ASTHMA TECHNOLOGY. The portfolio includes 1 registered trademark. Filings span 5 Nice Classification classes, led by Class 3 (Cosmetics & Cleaning) and Class 24 (Fabrics). This trademark owner is based in MORTON GROVE, IL.
8145 N. AUSTIN AVENUE
MORTON GROVE, IL 60053
Showing of trademarks Trademarks
Trademark Classifications
KMK HEALTH, LLC's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Frequently Asked Questions
How many trademarks does KMK HEALTH, LLC have?
KMK HEALTH, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 6 cancelled.
What trademark classes does KMK HEALTH, LLC file in?
KMK HEALTH, LLC files trademarks across 5 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 24 (Fabrics), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 11 (Environmental Control). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are KMK HEALTH, LLC's most well-known trademarks?
KMK HEALTH, LLC's registered trademark portfolio includes well-known marks such as ALLERGY ASTHMA TECHNOLOGY. These are among 1 currently registered trademark in the portfolio.
What is KMK HEALTH, LLC's trademark registration success rate?
KMK HEALTH, LLC has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.